Traws Pharma, Inc. (NASDAQ: TRAW)
$4.4500
-0.0146 ( -1.33% ) 3.3K
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Market Data
Open
$4.4500
Previous close
$4.4646
Volume
3.3K
Market cap
$13.68M
Day range
$4.3810 - $4.6700
52 week range
$4.1550 - $24.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 16 | Sep 17, 2024 |
| 8-k | 8K-related | 13 | Aug 23, 2024 |
| nt | Quarterly Reports | 1 | Aug 15, 2024 |
| 8-k | 8K-related | 14 | Aug 15, 2024 |
| 10-q | Quarterly Reports | 67 | Aug 15, 2024 |
| def | Proxies and info statements | 6 | Aug 09, 2024 |
| 4/a | Other | 1 | Aug 07, 2024 |
| 4/a | Other | 1 | Aug 07, 2024 |
| 8-k | 8K-related | 14 | Jul 19, 2024 |
| 8-k | 8K-related | 14 | Jun 28, 2024 |